<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p>Bleeding disorders may present at birth or develop later in life. The bleeding may be spontaneous or follow trauma or surgery and may be due to defective blood vessels, platelet disorders or clotting factor deficiency. Past episodes of excessive bleeding e.g. following circumcision, a family history of bleeding and drug therapy may be important clues to the diagnosis.</p><p>The pattern of bleeding is a helpful guide to its cause. In platelet and vessel wall defects, bleeding is usually into skin and mucosal surfaces like the gums, nose, gastrointestinal tract, whereas in coagulation factor deficiency (e.g. haemophilia), bleeding is into deep tissues like the brain, joints and muscles.</p><p>In newborns with vitamin K deficiency (which leads to multiple coagulation factor deficiency) spontaneous bleeding occurs from various sites such as the umbilical cord, gastrointestinal tract, scalp and brain.</p><p><strong>CAUSES</strong></p><ul><li>Haemophilia</li><li>Von Willebrand disease</li><li>Liver disease</li><li>Vitamin K deficiency especially in newborns</li><li>Bone marrow failure e.g. aplastic anaemia and leukaemia</li><li>Low platelet count from any cause</li><li>Disseminated Intravascular Coagulation (DIC) from any cause</li><li>Drug induced - herbal preparations, aspirin, clopidogrel, warfarin, rivaroxaban, heparin</li></ul><p><strong>SYMPTOMS</strong></p><ul><li>Spontaneous bleeding from mucous membranes or cuts</li><li>Easy bruising, bleeding from orifices</li><li>Excessive bleeding from cuts or incisions</li><li>Deformed joints from recurrent joint bleeds</li><li>Swelling at site of blood collection (pseudotumours)</li><li>Pain limiting movement</li></ul><p><strong>SIGNS</strong></p><ul><li>Pallor</li><li>Excessive bleeding</li><li>Localised swelling due to bleeding into body spaces e.g. Joints</li><li>Tenderness</li><li>Limitation of movement and joint deformities</li><li>Purpura, petechiae, ecchymosis</li></ul><p><strong>INVESTIGATIONS</strong></p><ul><li>FBC and blood film comment</li><li>Platelet count</li><li>Liver function tests</li><li>Prothrombin time, INR, partial thromboplastin time</li><li>Bleeding time </li></ul><p><strong>TREATMENT</strong> </p><p><strong>Treatment objectives</strong></p><ul><li>To prevent or arrest bleeding</li><li>To identify and correct underlying cause</li></ul><p><strong>Non-pharmacological treatment</strong></p><ul><li>Apply regulated pressure dressing and/or ice packs to minimise bleeding where possible</li><li>Stop any event/drugs responsible for bleeding or which may aggravate bleeding</li><li>Educate haemophiliacs on their disease, encouraging them to minimise trauma-prone activities, and to inform doctors of their condition before any surgical procedure</li><li>Avoid unnecessary injections and surgical procedures in all patients (especially, those with a family history of bleeding tendencies)</li><li>Physiotherapy on affected joints</li><li>Surgery</li></ul><p><strong>Pharmacological treatment</strong></p><p><strong>A. General Measures: fluid replacement following acute severe blood loss</strong></p><p>Sodium Chloride 0.9%, IV,</p><p>Adults</p><p>(See Section on '<a href="shock.html">Shock</a>') </p><p>Children and Neonates </p><p>20 ml/kg bolus stat.</p><p>Repeat if there is no clinical improvement</p><p><strong>And</strong></p><ul><li>Concentrated red cell transfusion, IV,</li></ul><p>Adults, Children and Neonates</p><p>3 ml/kg for each expected 1 g/dL haemoglobin rise</p><p><strong>B. Bleeding due to underlying liver disease</strong></p><p>1st Line Treatment </p><p>Evidence Rating: [A]</p><ul><li>Vitamin K, IV,</li></ul><p>Adults</p><p>5-10 mg stat.</p><p>Children</p><p>3-5 mg stat.</p><p>Neonates (irrespective of history of vitamin K injection) </p><p>Term;  1 mg stat.</p><p>Preterm; 500 micrograms stat.</p><p><strong>And</strong></p><ul><li>Fresh Frozen Plasma, IV, </li></ul><p>Adults, Children, Neonates </p><p>15-20 ml/kg</p><p><strong>C. Haemophilia A</strong></p><ul><li>Recombinant Factor VIII, intravenous,</li></ul><p>1 international unit raises % of Factor VIII on average by 2 per kg body weight</p><p>Required units = body weight (kg) x desired factor rise x 0.5 (Repeated as needed)</p><p><strong>Or</strong></p><ul><li>Desmopressin, Intranasal, 150 microgram spray into each nostril, 12 hourly. May be repeated for 3 days</li></ul><p><strong>D. Haemophilia B</strong></p><ul><li>Recombinant Factor IX</li></ul><p>Administration of 1 unit/kg factor IX (recombinant) generally in- creases factor IX levels by approximately 0.8% in adults and 0.7% in children &lt;15 years of age</p><p><strong>E. Von Willebrand Disease</strong></p><ul><li>Desmopressin, Intranasal, 150 microgram spray into each nostril, 12 hourly. May be repeated for 3 days</li></ul><p><strong>F. DIC</strong></p><p>Treat underlying cause.</p><ul><li>Fresh Frozen Plasma </li></ul><p>Adults, Children, Neonates </p><p>15-20 ml/kg</p><p><strong>Or</strong></p><ul><li>Coagulation factor, red cell and platelet concentrates as needed</li></ul><p><strong>G. Thrombocytopaenia requiring platelet transfusion</strong></p><ul><li>Platelet Concentrate</li></ul><p>Adults, Children, Neonates</p><p>10 ml/kg (raises platelet count by 5 x 109/L)</p><p>Prevention of local fibrinolysis</p><ul><li>Tranexamic Acid, oral and IV, </li></ul><p>100 mg/kg</p><p><strong>Then</strong></p><p>10 mg/kg</p><p>Adults</p><p>1300 mg oral 8 hourly</p><p><i><strong>2nd Line Treatment </strong></i></p><p>Evidence Rating: [A]</p><p><strong>Haemophilia A</strong></p><ul><li>Purified factor VIII</li><li>Cryoprecipitate, IV,</li></ul><p>Adults, Children, Neonates</p><p>1.5-2.0 packs/10 kg</p><p><strong>Haemophilia B</strong></p><ul><li>Purified factor IX</li><li>Fresh frozen plasma</li></ul><p><strong>REFERRAL CRITERIA</strong></p><p>Refer all haemophiliacs and all patients with unexplained recurring bleeding episodes and those requiring surgery to the physician specialist or haematologist for initial assessment, treatment plan and scheduled comprehensive review.</p>
</body>
</html>
